Equasens Société anonyme (EQS) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
29 Sep, 2026Executive summary
Revenue for H1 2026 reached €124.5M, up 7.3% year-over-year, driven by acquisitions, integration of new businesses, and strong organic growth.
Operating income rose 11.9% to €23.7M, with margin improvement to 19.0% due to favorable product mix and cost control.
Net income increased 10.5% to €20.0M, with EPS up 9.9% to €1.26.
Strong cash flow from operations (€33.1M), though working capital needs increased due to higher inventory.
ESG governance strengthened, with new board appointments and a reinforced sustainability roadmap.
Financial highlights
Revenue: €124.5M (+7.3% year-over-year), with ARR at €111.1M (+8.8%).
EBITDA: €33.3M (+11.9%), margin 26.8%; Operating income: €23.7M (+11.9%), margin 19.0%; Net income: €20.0M (+10.5%).
Net cash position improved to €93.2M at June 30, 2026, up €9.6M from December 2025.
Cash flow from operations: €33.1M, with increased investment in inventory and R&D.
Basic EPS increased 9.9% to €1.26.
Outlook and guidance
Continued investment in SaaS, Cloud, and AI integration to support long-term growth and leverage Ségur Reform opportunities.
Focus on expanding recurring revenue streams, high customer retention, and market coverage.
Confidence in the ability to pursue targeted investments in high-potential areas.
Latest events from Equasens Société anonyme
- 9M revenue grew 5.6% reported as Q4 Ségur Wave 2 deployments approach.EQS
Q3 2026 TU - Q1 2025 revenue rose 6.9% to €57.0m, driven by strong organic and SaaS growth.EQS
Q1 2025 TU - Q3 revenue returned to growth, driven by software gains, with Q4 growth expected.EQS
Q3 2024 TU - H1 2026 revenue rose 7.3% to €124.5M, led by innovation and European expansion.EQS
Q2 2026 TU - Q1 2026 revenue grew 7.7% to €61.4M, led by recurring revenue and divisional momentum.EQS
Q1 2026 TU - FY 2025 revenue rose 9.1% to €236.5M, with robust cash flow and strategic tech investments.EQS
H2 2025 - Revenue up 7.4% to €116.0m, stable profit, and strong growth in e-Connect and Medical Solutions.EQS
H1 2025 - Revenue and profit fell in H1 2024, but robust margins and investments support growth in H2.EQS
H1 2024 - 2024 profit fell on investments and weak H1, but 2025 targets strong AI-driven growth.EQS
H2 2024